Conclusion-Only five of 18 (28%) patients with pacemakers continued to pace long-term. Continued pacing was more common in those with persistent sinus node dysfunction after the second week after operation but the need for long-term pacing was not predictable. (Br Heart J' 1993;69:399-403) The usual resting heart rate after transplantation has been shown to be about 100 beats/min.'2 This is due to the absence of autonomic innervation and reflects the dominance of vagal tone in the normal heart. It compares closely with studies of the intrinsic heart rate in pharmacologically denervated hearts.3 In the first few weeks after transplantation sinus or junctional bradycardia occur in more than 50% of recipients.4 Donor sinus node dysfunction is the most common cause of bradyarrhythmia,4 although atrioventricular block is responsible in some patients.56 These early bradyarrhythmias are usually controlled by isoprenaline infusion or temporary epicardial pacing. In some patients bradycardia persists and permanent pacing may be needed. 4 5 7 Mackintosh et al suggested that sinus node dysfunction after transplantation indicated a very poor prognosis.8 This report led to the initial adoption of an aggressive early pacing policy at this and other centres.9
Patients-Al1 21 patients at this centre who had received permanent pacemakers after cardiac transplantation. 18 of 19 survivors completed the prospective part of the study. Main outcome measure-The presence of pacing during a 24 hour ambulatory electrocardiographic recording (programming: 50 beats/min, rate sensor inactivated). Results-21 of 191 (11%) recipients surviving one month or more received permanent pacemakers. The indication was sinus node dysfunction in 13 (62%) and atrioventricular (AV) block in eight (38%). Patients who paced on follow up 12 lead electrocardiograms declined from 38% at three months to 10% at three years after transplantation. After programming to 50 beatsimin only five of 18 (28%) patients paced during a 24 hour ambulatory recording. Four of 11 (36%) recipients who received pacemakers for sinus node dysfunction paced compared with one of seven patients (14%) paced for AV block. No patient who had a pacemaker before the 16th day after operation continued to pace whereas five of nine implanted later were used longterm.
Conclusion-Only five of 18 (28%) patients with pacemakers continued to pace long-term. Continued pacing was more common in those with persistent sinus node dysfunction after the second week after operation but the need for long-term pacing was not predictable.
(Br Heart J' 1993;69:399-403)
The usual resting heart rate after transplantation has been shown to be about 100 beats/min.'2 This is due to the absence of autonomic innervation and reflects the dominance of vagal tone in the normal heart. It compares closely with studies of the intrinsic heart rate in pharmacologically denervated hearts. 3 In the first few weeks after transplantation sinus or junctional bradycardia occur in more than 50% of recipients.4 Donor sinus node dysfunction is the most common cause of bradyarrhythmia,4 although atrioventricular block is responsible in some patients.56 These early bradyarrhythmias are usually controlled by isoprenaline infusion or temporary epicardial pacing. In some patients bradycardia persists and permanent pacing may be needed.4 5 7 Mackintosh et al suggested that sinus node dysfunction after transplantation indicated a very poor prognosis.8 This report led to the initial adoption of an aggressive early pacing policy at this and other centres. 9 Some authors have recently advocated complex modes of pacing in transplant patients who require permanent pacemakers.'0-2 It was our impression, however, that permanent pacemakers are often used for a short period after transplantation and complex pacing systems might be unnecessary. This study was therefore undertaken to assess the frequency and predictability of long-term pacing requirements in patients who had received permanent pacemakers after transplantation.
Patients and methods Between May 1985 and March 1992, 218 adults underwent orthotopic heart transplantation at this centre and 191 survived at least one month. The operative procedure was as described by Lower et al.13 Temporary epicardial atrial and ventricular pacing wires were placed at the time of operation in each patient and were removed around day 21 after operation.
In the early stages of our transplant programme VVI pacemakers were implanted between days 8 and 21 on a prophylactic basis when the resting heart rate was below 70 beats/min. Subsequently physiological and rate responsive systems were used as it was thought that these would improve exercise tolerance. The programmed rates were chosen to mimic heart rates achieved by other transplant patients without sinus or atrioventricular node dysfunction. A funrther review of our pacing policy was undertaken after an earlier study. ' The patients included in this study were identified retrospectively by the implantation of permanent pacemakers. Other patients with the rhythm disorders discussed who did not receive permanent pacemakers were therefore excluded. Although 12 lead electrocardiograms were available for all patients at the specified times after transplantation the ambulatory recordings were performed at variable times between three and 65 months. Single 24 hour ambulatory electrocardiograms provide insufficient data from which to be certain that the pacemakers are no longer required. Miyamoto et al however removed an infected pacemaker in one of their patients after 24 hours of ambulatory monitoring showed that there had been no pacing.5 Our data and previous electrophysiological studies, suggest improvements in sinus node function with time, and give some support to the conclusion that the pacemakers were no longer needed. Exercise tolerance was not formally assessed. We cannot therefore deny that some benefit results from pacing in patients who have no absolute requirement.
INDICATIONS FOR PERMANENT PACING
Sinus node dysfunction Sinus node dysfunction after transplantation has been widely reported and studied by electrophysiology.7816 The incidence varies from 50%8 early after transplantation (four to 24 days) to 29% 16 in long-term survivors (four to 14 months).
The natural history of sinus node dysfunction during the first year after transplantation has not been described. It is clearly of importance when attempting to assess the need for long-term pacing in these patients. Heinz et al reported that donor sinus arrest with or without junctional escape rhythm was predictive of persistent sinus node dysfunction,7 but electrophysiological indices were unhelpful.
Our overall implantation rate of 1 
Atnioventnicular block
There are no published data on the frequency and natural history of atrioventricular block after transplantation. Although it was common in one series,'7 in most it is much less common than sinus node dysfunction. Bexton et al found no evidence of atrioventricular block during electrophysiological studies in 14 patients at between four and 14 months after transplantation.'8 Miyamoto et al described a slow ventricular response to atrial fibrillation and flutter in 1% (4/401) of transplant recipients.5 This resolved within 20 days and permanent pacing was not required. In the series published by DiBiase et al 10% of pacemakers were implanted for various degrees of atrioventricular block9 compared with 38% in our series. Our limited data from 12 lead electrocardiograms suggest that atrioventricular block after transplantation usually resolves within three to six months.
TIMING OF PACING
In this study no patient who received a pacemaker before day 15 after operation continued to need a pacemaker long-term. Some authors have advocated pacing at between seven and 10 days after transplantation. '9 This policy, however, may lead to unnecessary implantations particularly in patients with sinus node dysfunction that may continue to resolve throughout the first month. In patients receiving atrial pacemakers the integrity of the atrioventricular conduction system is routinely tested by incremental atrial pacing and measurement of the Wenckebach point. There is no evidence to support concerns about the subsequent development of atrioventricular block in these patients.
In general the prescription of a rate adaptive pacemaker should be based on observed chronotropic incompetence. The chronotropic response to exercise is abnormal in all transplant recipients29 because of autonomic denervation. The resting heart rate is high but there is a delayed and blunted response of heart rate to exercise. There is, however, no evidence that rate adaptive pacing can improve on the chronotropic response of the normal sinus node after transplantation. Although the theoretical benefits of a recipient atrium sensing system are clear,'0 the high incidence of recipient sinus node dysfunction may limit the general applicability of this technique.'6 It also remains to be shown whether there is a significant clinical advantage.
The need for long-term pacing in transplant recipients receiving pacemakers soon after transplantation is infrequent. Those with sinus node dysfunction are more likely to require long-term pacing than those with atrioventricular block.
There are, however, at present no clear prognostic indicators of subsequent pacing requirements in those with persistent bradyarrhythmias after the third week. A pacing system suitable for long-term use should therefore be selected. We recommend that implantation is delayed until at least 21 days after transplantation and until the patient is otherwise ready for discharge from hospital in order to reduce the frequency of unnecessary implantations.
The mode of pacing should be selected on an individual basis. Although there is no specific evidence of the superiority of physiological or rate responsive pacing in transplant recipients, the advantages in other patients are clearly established. Physiological pacing should probably be used where possible and rate adaptive systems used for those patients with confirmed chronotropic incompetence.
